It might be time to start shopping “down market”, says Jennifer Hughes in the Financial Times. The Russell 2000 index of US small and mid-sized firms has been having a miserable year, gaining less than 1% even as the large-cap S&P 500 soars 17.5%.
Over six months, “small caps have only underperformed their bigger cousins this badly at two other points since the 2000 dotcom boom”. While mega caps rocket due to artificial intelligence fever – Nvidia alone is now “worth roughly as much as the entire Russell 2000” – struggling small caps suggest that the wider American economy is lethargic.
US small caps and mid caps have generally under-performed US large caps over the past 10 years, says J.P.Morgan’s Sitara Sundar. They are thus trading “at a near record valuation discount” to their large-cap peers. US small and mid-caps are at “the leading edge of innovation”, whether in software or advances in industrial automation. But small and mid caps vary in quality.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
For every exciting small cap, there are ones that “carry high levels of debt or do not generate earnings”, so “active stock picking” is key. Some investors buy small companies in pursuit of the “small-cap premium”, says Ben Carlson on his A Wealth of Common Sense blog. Between 1926 and 2021, US small-cap stocks outperformed large-cap stocks by more than 10%.
“Others dispute whether the premium is real, but whatever the truth, small caps are invaluable as a portfolio diversifier”. That’s especially true in periods like today where large-cap valuations are vulnerable to a reversal.
“The last time small caps lagged in a big way was the late 1990s when the dotcom bubble went into hyperdrive”. When the bubble burst, it was the undervalued small caps that “outperformed in a big way during the next cycle”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
Rightmove: UK asking prices hit record high but Britain enters buyer’s marketHigher property taxes are stifling the typically-busy spring selling season and buyers are benefiting from more choice, meaning sellers must price their homes more competitively
-
Inheritance tax reforms: government urged to rethink curbs on rural reliefsMPs want the government to delay changes to inheritance rax reliefs for farmers
-
'Pension funds shouldn't be pushed into private equity sector'Opinion The private-equity party is over, so don't push pension funds into the sector, says Merryn Somerset Webb.
-
Greg Abel: Warren Buffett’s heir takes the throneGreg Abel is considered a safe pair of hands as he takes centre stage at Berkshire Hathaway. But he arrives after one of the hardest acts to follow in investment history, Warren Buffett. Can he thrive?
-
Who will be the next Warren Buffett?Opinion There won’t be another Warren Buffett. Times have changed, and the opportunities are no longer there, says Matthew Lynn.
-
Will Comstock crash – or soar?Opinion The upside for Comstock, a solar panel-recycling and biomass-refining group, dwarfs the downside, says Dominic Frisby.
-
'As AGMs go digital, firms must offer a new form of scrutiny for shareholders'Opinion Technology has rendered big AGM meet-ups obsolete, but the board still needs to be held to account, says Matthew Lynn
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
-
Two ways to tap into monopoly profits from airportsMost investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?The latest weight-loss treatments could transform public health and the world economy. Should you invest?
